EN
EN
Product
Technology
Indication
Pre-clinical
Phase I/Clinical trials
Phase II/III*
NDA/BLA
A100S
ASPIRE
Ovarian, Cervical, Endometrial and Lung cancer, Testicular tumor, and other solid tumors
I301
ASPIRE ARMORS
Glioma
L200s
TRUST ARMORS
NPC and NKT lymphoma
N201
TRUST ARMORS
synovial sarcoma, lung cancer, and other solid tumors
H101
Tumor vaccine
DIPG
G201
ASPIRE ARMORS
Liver cancer, Digestive system tumor, and other solid tumors
D201
ASPIRE ARMORS
Small cell lung cancer, Neuroendocrine tumors
K201
TRUST ARMORS
Lung, Bowel, Pancreatic cancer, and other solid tumors
HBV100S
TRUST
Liver cancer
